Biogen Idec IncBIIB:NSQ

301.56
4.64 / 1.52%
884.83k
41.74%
1.20
Real-time price in USDToday's changeShares traded1 year changeBeta
As of Apr 23 2014 16:02 BST.

Summary

As of last trade Biogen Idec Inc (BIIB:NSQ) traded at 301.56, 15.97% below its 52-week high of 358.89, set on Mar 19, 2014.

52-week range
Today
194.66
Jun 21 2013
358.89
Mar 19 2014
Markit short selling activity
Low
Medium
High
Open309.00
Day high311.10
Day low295.49
Bid300.48
Offer301.74
Previous close306.20
Average volume1.87m
Shares outstanding236.39m
Free float236.16m
P/E (TTM)39.18
Market cap72.38bn USD
EPS (TTM)7.82 USD

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Biogen Idec Inc+3.12%-5.64%+19.70%+41.28%+553.72%
S&P 500 INDEX+0.93%+0.70%+7.63%+19.05%+120.63%
USA/HEALTH CARE+2.21%-0.52%+9.23%+17.17%--
USA/BIOTECHNOLOGY+4.11%-2.10%+5.30%+19.65%--
As of Apr 23 2014 15:47 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

Real-time data provided by BATS.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.